Selma Diagnostics ApS: Financial statements 2017
CVR: 36961376
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Selma Diagnostics ApS (CVR 36961376) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,928,065 and a net result of DKK -2,251,061. Equity in the 2017 report amounted to DKK 4,101,802. The solvency ratio was 98.2%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,928,065
- Profit/Loss
- DKK -2,251,061
- Equity
- DKK 4,101,802
- Total Assets
- DKK 4,175,041
- Employees
- 2
Keep an eye on Selma Diagnostics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of September 8, 2017, Milan Zdravkovic has joined the board of directors of Selma Diagnostics ApS.
As of September 8, 2017, Søren Frits Lybecker has left the board of directors of Selma Diagnostics ApS.
Selma Diagnostics ApS has published its interim report for the period July 10, 2015 – December 31, 2016.
About Selma Diagnostics ApS
Selma Diagnostics ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Andreas Hjarne Kunding. The board consists of Carsten Krogh Gomard (chair), Andreas Hjarne Kunding and John Alexander. The company's owners include John Alexander, CARSTEN GOMARD HOLDING ApS and Selma Diagnostics ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -1,093,508 and a net result of DKK -3,060,808 compared with DKK -2,178,400 the year before. Equity in the 2025 report amounted to DKK -11,154,823.